Literature DB >> 7949359

Control of rabbit myxomatosis in Poland.

J Górski1, B Mizak, M Chrobocińska.   

Abstract

The authors present an epizootiological analysis of myxomatosis in Poland. The biological, physical and chemical properties of virus strains used for the production and control of 'Myxovac M' vaccine are discussed. The long-term stability, safety and efficacy of the vaccine are demonstrated. Laboratory experiments were confirmed in large-scale field observations.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7949359     DOI： 10.20506/rst.13.3.803

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN： 0253-1933            Impact factor:   1.181


  9 in total

1.  Histological evaluation of intratumoral myxoma virus treatment in an immunocompetent mouse model of melanoma.

Authors:  Rosalinda A Doty; Jia Liu; Grant McFadden; Edward J Roy; Amy L MacNeill
Journal:  Oncolytic Virother       Date:  2013-01

2.  Genetic Variability of Myxoma Virus Genomes.

Authors:  Christoph Braun; Andrea Thürmer; Rolf Daniel; Anne-Kathrin Schultz; Ingo Bulla; Horst Schirrmeier; Dietmar Mayer; Andreas Neubert; Claus-Peter Czerny
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

3.  Apoptosis-inducing effect of myxoma virus on human neuroglioma cell lines.

Authors:  Qiu-Sheng Zhang; Meng Zhang; Xian-Jian Huang; Xiao-Jia Liu; Wei-Ping Li
Journal:  Exp Ther Med       Date:  2017-05-22       Impact factor: 2.447

4.  Genome sequence of SG33 strain and recombination between wild-type and vaccine myxoma viruses.

Authors:  Christelle Camus-Bouclainville; Magalie Gretillat; Robert Py; Jacqueline Gelfi; Jean Luc Guérin; Stéphane Bertagnoli
Journal:  Emerg Infect Dis       Date:  2011-04       Impact factor: 6.883

5.  Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma.

Authors:  Amy L MacNeill; Kristen M Weishaar; Bernard Séguin; Barbara E Powers
Journal:  Viruses       Date:  2018-07-28       Impact factor: 5.048

6.  Myxoma virus therapy for human embryonal rhabdomyosarcoma in a nude mouse model.

Authors:  Veronica G Kinn; Valerie A Hilgenberg; Amy L MacNeill
Journal:  Oncolytic Virother       Date:  2016-08-08

Review 7.  On the potential of oncolytic virotherapy for the treatment of canine cancers.

Authors:  Amy L MacNeill
Journal:  Oncolytic Virother       Date:  2015-08-26

8.  Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib.

Authors:  Laura V Ashton; Barbara Graham; Maryam F Afzali; Daniel Gustafson; Amy L MacNeill
Journal:  Oncolytic Virother       Date:  2020-05-26

9.  Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits.

Authors:  Laura V Ashton; Sandra L Quackenbush; Jake Castle; Garin Wilson; Jasmine McCoy; Mariah Jordan; Amy L MacNeill
Journal:  Viruses       Date:  2020-05-08       Impact factor: 5.048
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.